Sanyou Bio's Intelligent Super-trillion Molecule Discovery Platform consists of ten sub-platforms, encompassing a variety of molecular types. These include super-trillion fully human antibody ...

Harbour BioMed, Insilico Medicine enter strategic collaboration to advance AI-driven antibody discovery and development: Cambridge, Massachusetts Saturday, February 22, 2025, 14:0 ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and ...

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and ...

February 20, 2025, Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...